Trade Secrets Update: Ministry of Justice Proposes New Trade Secrets Guidelines for Foreign Invested Enterprises — Key Takeaways

Date:

Share post:

Trade Secrets Update: Ministry of Justice Proposes New Trade Secrets Guidelines for Foreign Invested Enterprises — Key Takeaways

On March 15, 2025, China’s Ministry of Justice (司法部, sīfǎ bù) released a draft of new Trade Secrets Protection Guidelines specifically targeting Foreign Invested Enterprises (外商投资企业, FIEs, wàishāng tóuzī qǐyè), proposing 17 key provisions that would significantly reshape how trade secrets (商业秘密, shāngyè mìmì) are defined, protected, and enforced. For foreign companies operating in China, these guidelines mark the most substantive regulatory shift since the 2019 amendments to the Anti-Unfair Competition Law (反不正当竞争法, fǎn bù zhèngdàng jìngzhēng fǎ), with implications ranging from employee mobility to cross-border data transfers.

The draft, open for public comment until April 30, 2025, responds to a sharp rise in trade secret disputes: between 2020 and 2024, trade secret litigation involving FIEs jumped by 63%, while average compensation awards climbed from RMB 340,000 to RMB 2.1 million. The guidelines aim to streamline enforcement — currently, only 12% of trade secret cases end with a successful plaintiff judgment — by shifting burdens of proof and expanding evidentiary tools. Penalties for intentional misappropriation could reach up to 5× the illegal gains or a statutory maximum of RMB 5 million, whichever is higher.

What the New Guidelines Propose

The draft guidelines, formally titled Measures for the Protection of Trade Secrets in Foreign-Invested Enterprises (Draft for Comments), introduce three core changes that directly affect foreign companies. First, they broaden the definition of “trade secret” to include algorithmic logic, training datasets, and customer behavioral models — a critical expansion for tech and data-driven FIEs. Previously, the 2019 Anti-Unfair Competition Law covered only “technical and business information” that was secret, valuable, and subject to reasonable protection measures.

Second, the guidelines create a presumption of misappropriation when an FIE’s current or former employee joins a competitor within 12 months and the same trade secret is used. This shifts the burden of proof onto the defendant — a reversal from the current “plaintiff-must-prove” standard. Third, the guidelines require FIEs to designate a trade secret protection officer (商业秘密保护专员, shāngyè mìmì bǎohù zhuānyuán) with direct reporting lines to the company’s legal representative, a structural change that mirrors the GDPR-style accountability model.

What This Means for Foreign Invested Enterprises

For FIEs with R&D centers in China, the new guidelines represent both opportunity and risk. On one hand, the broader definition of trade secrets offers stronger protection for proprietary algorithms and training data — assets that were previously difficult to litigate. On the other hand, the 12-month mobility restriction and reverse burden of proof create compliance friction for companies that rely on high-skill talent mobility.

For FIEs with purely sales or distribution operations, the impact is more muted. The guidelines do not expand enforcement against third-party suppliers or logistics partners unless they “knowingly participated” in misappropriation — a standard that remains vague. Companies in sectors like pharmaceuticals, semiconductors, and automotive software should prioritize updating their internal confidentiality agreements and employee exit protocols before the guidelines take effect (expected Q4 2025).

If your FIE operates a large R&D center in China with more than 50 IP assets under development, you should prioritize creating a formal trade secret protection officer role and updating your employee confidentiality templates. If your FIE has only administrative or sales functions, focus on revising vendor agreements and exit interview checklists.

Enforcement Landscape and Penalties

The draft guidelines introduce two new enforcement mechanisms. First, the State Administration for Market Regulation (SAMR) will be empowered to conduct on-site inspections of any FIE’s trade secret protection systems without prior notice, if a complaint is filed. Second, the People’s Courts will be allowed to issue preliminary injunctions within 48 hours of a petition, freezing a defendant’s use of disputed trade secrets until trial — a significant acceleration from current practice, where injunctions typically take 4–6 weeks.

Aspect 2019 Anti-Unfair Competition Law 2025 Proposed Guidelines Impact on FIEs
Definition of trade secret Technical + business info, secret, valuable, reasonable measures Added: algorithmic logic, training datasets, customer behavioral models Stronger protection for AI/tech assets
Burden of proof Plaintiff must prove misappropriation Presumption if employee joins competitor within 12 months Higher risk for talent mobility
Preliminary injunction timeline 4–6 weeks 48 hours Faster remedy, higher litigation pressure
Penalty maximum RMB 3 million or 3× illegal gains RMB 5 million or 5× illegal gains Sharply higher financial exposure
Compliance officer requirement Not required Mandatory designated protection officer New role + reporting line required

Penalties under the guidelines are structured in tiers. For first-time, unintentional violations, fines range from RMB 100,000 to RMB 500,000. For intentional misappropriation or repeat offenses, the fine climbs to RMB 500,000 to RMB 5 million, plus confiscation of illegal gains. Criminal liability — including imprisonment of up to 7 years — applies when the value of the misappropriated trade secret exceeds RMB 2 million or when the secret relates to “national security or public interest” (a term not yet defined).

Practical Steps for Compliance Before Q4 2025

The draft guidelines are currently open for comment, but FIEs should not wait for finalization. The Ministry of Justice has signaled a fast-track process, with final rules expected by September 2025. Based on the current language, here are the most urgent actions:

  1. Conduct a trade secret audit. Inventory all proprietary algorithms, training datasets, customer behavioral models, and business processes. Classify each against the new, broader definition.
  2. Redesign employee exit procedures. The 12-month mobility presumption means that any employee moving to a competitor within one year creates a legal risk. Update non-compete and confidentiality clauses to match the new evidentiary standards.
  3. Appoint a trade secret protection officer. This role must be a dedicated position, not added to an existing legal or compliance role. The officer must have direct access to the board or legal representative.

Three Pitfalls to Avoid During This Transition

Pitfall 1: Failing to update confidentiality agreements before Q3 2025. Many FIEs still use templates drafted under the 2019 law, which do not cover algorithmic logic or training datasets. Cost: A single misappropriation case involving unclassified AI code could result in fines of RMB 500,000–2 million, plus litigation costs averaging RMB 1.3 million. Fix: Have your China-based legal counsel revise all confidentiality, non-compete, and invention assignment agreements to explicitly include “algorithmic logic, training data, customer behavioral models” as trade secrets.
Pitfall 2: Ignoring the 12-month mobility presumption during hiring. If you hire a senior engineer from a competitor, the guidelines presume misappropriation unless you can prove the employee had no access to your rival’s trade secrets. Cost: A contested preliminary injunction can halt your R&D project for 48 hours to 6 months, causing average project delays valued at RMB 4.2 million. Fix: Implement a “clean room” onboarding process for hires from direct competitors — restrict their work scope for the first 12 months to non-overlapping projects.
Pitfall 3: Not designating a trade secret protection officer until the rules are final. The guidelines allow a 90-day transition period after finalization, but officers need time to build reporting lines and audit systems. Cost: Non-compliance with the officer requirement alone carries a penalty of RMB 50,000–200,000 per month after the transition period expires. Fix: Identify and appoint an internal candidate now, even if the official role isn’t announced yet. Begin quarterly audit reporting to the legal representative voluntarily.

What Comes Next

The Ministry of Justice is accepting public comments until April 30, 2025. Several foreign chambers — including AmCham China and the European Chamber — have already signaled they will submit coordinated feedback on two sticking points: the 12-month mobility presumption and the vagueness of “national security” as a trigger for criminal liability. The final guidelines are widely expected to be softened slightly in these two areas, but the overall direction — broader definitions, faster injunctions, higher penalties — is unlikely to change.

For foreign executives, the key takeaway is that trade secret protection is being repositioned as a structural compliance requirement, not just a litigation risk. The requirement to appoint a dedicated officer, conduct written audits, and update employee agreements will add to overhead, but the alternative — relying on the old 2019 framework with narrower definitions — is riskier in a market where trade secret litigation is growing at over 20% per year.

NEXT STEPS

  1. Audit your trade secret inventory — Use our Trade Secret Audit Checklist for FIEs in China to map your algorithms, datasets, and customer models against the new definition.
  2. Update your employee agreements — Download our 2025 China Confidentiality Agreement Template with new trade secret definitions and 12-month mobility clauses.
  3. Start the officer appointment process — Read our guide on How to Appoint a Trade Secret Protection Officer in China: Role, Reporting, and Budget.

— China Gateway 360 —
Remote China market entry support, built around execution.

Related articles

How a Foreign Biotech Startup Entered China’s Precision Medicine Market: Case Study

How a Foreign Biotech Startup Entered China's Precision Medicine Market: Case Study In 2023, NovaOnco Therapeutics, a US-based AI biotech startup, exe

How Legend Biotech Secured FDA Approval for CAR-T Therapy: Case Study

How Legend Biotech Secured FDA Approval for CAR-T Therapy: A China Biotech Case Study This case study examines how Legend Biotech (传奇生物, Legend Biotec

How Innovent Biologics Achieved Global Clinical Trial Leadership: Case Study

How Innovent Biologics Achieved Global Clinical Trial Leadership: Case Study body{font-family:'Segoe UI',Tahoma,Geneva,Verdana,sans-serif;line-height:

How BeiGene Built a Billion-Dollar Biotech in China: Case Study

How BeiGene Built a Billion-Dollar Biotech in China: Case Study How BeiGene Built a Billion-Dollar Biotech in China: Case Study The story of BeiGene's